Menu
Recruiting NCT06982989

Clinical Study on the Treatment of Pelvic Pain With Wearable Dual-band LED Device

No phase Interventional Pelvic Pain

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: use LED to treat pelvic pain.
Who it may be relevant to
Registry conditions: Pelvic Pain. Basic parameters: 18 years — 35 years · Female.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
China
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

This study is a prospective clinical trial, which intends to prospective include female pelvic pain (dysmenorrhea and chronic pelvic pain), screen suitable cases, wear dual-band LED devices in non-menstrual period, perform low-dose phototherapy on local pelvic area and acupoints, and observe the changes of pelvic pain and related serological indicators in clinical practice.

Interventions

  • Device use LED to treat pelvic pain
    Use led to treat pelvic pain

Primary outcome measures

  • Efficacy that LED release pelvic pain [Time frame: 1 month after the treatment]

Eligibility criteria

Inclusion criteria

  • pelvic pain

Exclusion criteria

  • Irregular menstrual cycles;
  • Inflammatory disease;
  • pregnant;
  • Light allergy;

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
N/A
Model
Single group
Masking
Open label
Primary purpose
Treatment

Study locations

China · 1 center
  • Peking Unniversity Third Hospital — Beijing

Identifiers

NCT: NCT06982989 · LED Pelvic pain · 2022YFB3604705

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗